Related Experiment Videos
[The thrombocyte function of bronchial asthma patients]
Terapevticheskii Arkhiv
|January 1, 1990
Summary
Platelets in atopic and aspirin-sensitive asthma patients show heightened reactivity to platelet-activating factor (PAF). This hyper-response, characterized by increased aggregation and calcium influx, distinguishes them from other asthma types and healthy individuals.
Area of Science:
- Immunology
- Hematology
- Pulmonology
Background:
- Asthma involves complex immune dysregulation.
- Platelet activation plays a role in inflammatory airway diseases.
- Distinct asthma phenotypes may exhibit unique platelet functional characteristics.
Purpose of the Study:
- To investigate and compare platelet functional characteristics in different asthma phenotypes.
- To assess platelet sensitivity to platelet-activating factor (PAF) in atopic, aspirin-sensitive, and mixed asthma.
- To evaluate the impact of antiallergic drugs on platelet activation in asthma.
Main Methods:
- Platelet aggregation measured using Born's method and correlational photometry.
- Intracellular calcium (Ca2+) influx assessed with the fluorescent probe Fura-2.
- Platelet-activating factor (PAF) used as the primary stimulus.
Main Results:
- Platelets from atopic and aspirin-sensitive asthmatics demonstrated significantly higher aggregation and Ca2+ influx in response to PAF compared to mixed asthma and healthy controls.
- Platelets in atopic and aspirin-sensitive asthma exhibited increased activation and a lower threshold for PAF-induced responses.
- Ketotifen and sodium cromoglycate inhibited PAF-induced platelet aggregation by 30-40% in both asthmatic and healthy subjects.
Conclusions:
- Platelets in atopic and aspirin-sensitive asthma are hyper-reactive to PAF, indicated by enhanced aggregation and Ca2+ signaling.
- This platelet hyper-reactivity may contribute to the pathophysiology of specific asthma subtypes.
- Antiallergic drugs show potential in modulating aberrant platelet activation in asthma.